ArticleMolecular cancer therapeutics2022

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models.

Valentí Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.